Peter Schäfer

机构：Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (United States), Lupus Research Alliance, Bristol-Myers Squibb (Belgium) · ORCID：0000-0002-3880-0850

发表论文 335 篇 · 总被引 14871 次 · h-index 62

代表论文

• Prognostic Significance and Biologic Associations of Senescence‐Associated Secretory Phenotype Biomarkers in Heart Failure (2024 · Journal of the American Heart Association · 被引 23)
• Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways (2024 · Frontiers in Immunology · 被引 8)
• Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: A randomized phase 2 clinical trial (2024 · Journal of the American Academy of Dermatology · 被引 7)
• Responsiveness of systemic lupus erythematosus subjects to iberdomide based on molecular endotypes (2025 · Annals of the Rheumatic Diseases · 被引 5)
• Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction (2024 · Journal of the American Heart Association · 被引 5)
• Subphenogroups of acute heart failure with preserved ejection fraction: comprehensive proteomics and pathway analysis (2025 · Heart · 被引 2)